• Canada
• Research softwareclose
• Other research productsclose
• US close
• English close

https://viurrspace.ca/bitstream/handle/10613/21933/Feb27-1878.pdf?sequence=2

https://viurrspace.ca/bitstream/handle/10613/11898/Apr03-1922.pdf?sequence=2&isAllowed=y

https://viurrspace.ca/bitstream/handle/10613/19845/Aug29-1894.pdf?sequence=2

https://viurrspace.ca/bitstream/handle/10613/7023/July07-1910.pdf?sequence=2

This report provides a strategic analysis of a small sized engineering firm competing in the British Columbia, Canada region. The analysis focuses on how to increase the firm’s profitability by examining its internal structure and the external environment. The analysis considered the relative growth of the industry and reviewed potential opportunities and threats. It analysed the firm’s competitiveness in each of the market segments and reviewed means by which it could increase its competitiveness. The analysis showed that the firm competes well within the current segments it operates in and has the potential to be competitive in a new market segment. The analysis developed several strategic alternatives to meet the firm’s key goals. Based on the potential of each alternative to achieve the firm’s goals a preferred option of allocating non-billable time to expanding workload was recommend. The workload expansion included the First Nations and private development segments the firm currently competes in, as well as expanding into the municipal government segment where the firm showed potential to be competitive.

https://viurrspace.ca/bitstream/handle/10613/19851/Aug07-1894.pdf?sequence=2

https://viurrspace.ca/bitstream/handle/10613/15305/Sep07-1901.pdf?sequence=2

A growing body of literature on the 2019 novel coronavirus (SARS-CoV-2) is becoming available, but a synthesis of available data has not been conducted. We performed a scoping review of currently available clinical, epidemiological, laboratory, and chest imaging data related to the SARS-CoV-2 infection. We searched MEDLINE, Cochrane CENTRAL, EMBASE, Scopus and LILACS from 01 January 2019 to 24 February 2020. Study selection, data extraction and risk of bias assessment were performed by two independent reviewers. Qualitative synthesis and meta-analysis were conducted using the clinical and laboratory data, and random-e ects models were applied to estimate pooled results. A total of 61 studies were included (59,254 patients). The most common disease-related symptoms were fever (82%, 95% confidence interval (CI) 56%–99%; n = 4410), cough (61%, 95% CI 39%–81%; n = 3985), muscle aches and/or fatigue (36%, 95% CI 18%–55%; n = 3778), dyspnea (26%, 95% CI 12%–41%; n = 3700), headache in 12% (95% CI 4%–23%, n = 3598 patients), sore throat in 10% (95% CI 5%–17%, n = 1387) and gastrointestinal symptoms in 9% (95% CI 3%–17%, n=1744). Laboratory findings were described in a lower number of patients and revealed lymphopenia (0.93 109/L, 95% CI 0.83–1.03 109/L, n = 464) and abnormal C-reactive protein (33.72 mg/dL, 95% CI 21.54–45.91 mg/dL; n = 1637). Radiological findings varied, but mostly described ground-glass opacities and consolidation. Data on treatment options were limited. All-cause mortality was 0.3% (95% CI 0.0%–1.0%; n = 53,631). Epidemiological studies showed that mortality was higher in males and elderly patients. The majority of reported clinical symptoms and laboratory findings related to SARS-CoV-2 infection are non-specific. Clinical suspicion, accompanied by a relevant epidemiological history, should be followed by early imaging and virological assay.

We provide an initial checklist of the herpetofauna of Baramita, a lowland rainforest site in the Northwest Region of Guyana. Twenty-five amphibian and 28 reptile species were collected during two separate dry-season visits. New country records for two species of snakes are documented, contributing to the knowledge on the incompletely known herpetofauna of Guyana.